Apple Inc. has launched a new challenge at the Patent Trial and Appeal Board, filing inter partes review petition IPR2026-00438 on August 17, 2026. At this early stage, the docket signals the opening of another high-stakes PTAB contest involving one of the most active technology companies in the patent arena. For practitioners tracking repeat PTAB filers, portfolio pressure campaigns, or parallel district court strategy, this is a proceeding worth watching.

The petitioner is Apple Inc.. Based on the currently available case information, Apple is seeking PTAB review of an issued patent, with the patent owner and the specific patent number expected to become clearer as the petition and related filings are further reflected on the docket.

A new petition at the Patent Trial and Appeal Board, IPR2026-00413, was filed on August 14, 2026, and names Luxottica of America Inc. in the proceeding caption. For patent practitioners tracking activity in the eyewear, retail, consumer products, or branded technology spaces, this is a matter worth watching as the record develops.

At this early stage, the publicly available docket information identifies the proceeding title, filing date, and PTAB docket number, but key details that practitioners will want—most notably the patent number being challenged, the full party alignment between petitioner and patent owner, and the specific invalidity grounds asserted under 35 U.S.C. §§ 102 and/or 103—will likely become clearer as the petition and accompanying papers are added to the docket.

That said, the filing itself is significant.

The Eleventh Circuit’s August 7, 2026 filing in Opinion, No. 25-13883, is now available on Docket Alarm. At the time of writing, the key takeaway for practitioners is the release of the appellate disposition itself and the need to review the opinion closely for its treatment of the issues on appeal, procedural posture, and any statements that may affect future briefing strategy in the circuit.

Because appellate opinions can turn on narrow procedural grounds as often as on merits questions, lawyers should focus first on three things: what judgment the panel entered, whether the court affirmed, reversed, vacated, or remanded; the standard of review it applied; and whether the holding is expressly limited to the facts before it or framed in broader doctrinal terms.

The Third Circuit’s August 5, 2026 opinion in No. 25-3032 is now available, but practitioners should note an immediate limitation for analysis: the public case information provided here identifies the court, docket number, and filing date, but does not include the text of the opinion itself. That means any substantive assessment of the panel’s holding, its reasoning, or its precedential effect depends on reviewing the opinion directly.

For lawyers tracking developments in the Third Circuit, that distinction matters.

The Tenth Circuit’s August 4, 2026 order in appeal No. 26-6021 appears to be a procedural disposition rather than a published merits opinion, and that matters for how practitioners should read it.

A new inter partes review, IPR2026-00408, was filed at the Patent Trial and Appeal Board on July 28, 2026, under the caption Zhuhai CosMX Battery Co., Ltd. For patent practitioners tracking battery-sector disputes and PTAB filing trends, this is a proceeding worth watching as the record develops.

At this early stage, the publicly available docket information identifies the petitioner as Zhuhai CosMX Battery Co., Ltd., but the initial case caption alone does not yet provide the full picture of the challenged patent, the patent owner, or the specific prior-art combinations being asserted.

Google LLC has filed a new inter partes review petition at the Patent Trial and Appeal Board, opening IPR2026-00421 on July 13, 2026.

The Supreme Court has handed down a major administrative-law ruling, siding with President Donald Trump in a dispute over the firing of FTC Commissioner Rebecca Slaughter and sharply expanding presidential removal authority over independent agencies. In doing so, the Court overruled Humphrey’s Executor v. United States, the 1935 precedent that had long been understood to shield FTC commissioners from removal except for cause.

The case, Donald J. Trump, President of the United States, et al., Petitioners v. Rebecca Kelly Slaughter, is likely to become a cornerstone decision in the Court’s modern separation-of-powers jurisprudence.

A new inter partes review, IPR2026-00416, was filed on July 9, 2026 at the Patent Trial and Appeal Board, naming McCormick Company, Inc. in the proceeding. For patent practitioners tracking food technology, consumer products, and brand-adjacent innovation disputes, this is the kind of PTAB filing worth watching from the outset.

At this early stage, the docket information publicly available from the case caption primarily identifies the proceeding by the patent owner name, McCormick Company, Inc.. As is typical in a newly filed IPR, the key issues will center on which McCormick patent is being challenged, who the petitioner is, and whether the petition presents prior art grounds strong enough to justify institution. Those details often shape not only the PTAB strategy, but also any parallel district court or licensing dynamics.

In general, an IPR petition asks the Board to review the validity of one or more patent claims based on prior art patents or printed publications, usually under 35 U.S.C. §§ 102 or 103. Once the petition and supporting papers are fully available, practitioners will want to examine the asserted references, claim constructions, any expert declaration support, and whether the petitioner is pressing a narrow claim-focused attack or attempting a broader invalidation campaign.

This case may be especially relevant for in-house IP counsel and outside litigators because PTAB challenges involving established commercial players like McCormick can reveal a great deal about how competitors or accused infringers are approaching ingredient, formulation, packaging, processing, or related patent portfolios. Even before institution, the filing can signal market pressure points, identify art that may be reused against related family members, and preview arguments that could spill into co-pending litigation or post-grant strategy.

Patent owners will also want to watch for familiar procedural themes: discretionary denial issues, real-party-in-interest disputes, the sufficiency of motivation-to-combine arguments, and whether the petition relies on teachings that map cleanly onto the challenged claims.

The U.S. Supreme Court has handed down a major administrative-law ruling with immediate consequences for federal agencies, regulated businesses, and the lawyers who advise them.

A new post-grant review at the Patent Trial and Appeal Board is worth watching for practitioners tracking early-life patent challenges and the evolving use of PTAB proceedings against recently issued patents. In PGR2026-00064, titled ShoreShade LLC, the petition was filed on July 1, 2026. The proceeding is now on the radar for patent owners, petitioners, and IP counsel evaluating how aggressively to use post-grant review in high-stakes disputes.

At this stage, the docket caption identifies ShoreShade LLC as the patent owner in the PTAB proceeding.

A federal judge in Washington has preliminarily blocked the Defense Department from forcing New York Times reporters to be accompanied by escorts while they pursue their challenge to Pentagon press-access restrictions, a ruling that signals meaningful judicial skepticism toward the policy under the First Amendment.

The dispute, now pending as NEW YORK TIMES COMPANY et al v. DEPARTMENT OF DEFENSE et al, centers on whether the Pentagon can impose differential access burdens on a major news organization in a way that appears to impede routine newsgathering.

A new post-grant review, PGR2026-00062, was filed at the Patent Trial and Appeal Board on June 25, 2026, putting an America Ugreen Limited patent directly in the PTAB spotlight.

A new inter partes review filed at the Patent Trial and Appeal Board could be one to watch for companies operating at the intersection of life sciences, nutraceuticals, and consumer health. In IPR2026-00400, the proceeding is captioned Thorne Research, Inc. and was filed on June 22, 2026.

At this early stage, the PTAB docket signals that a patent challenge involving Thorne Research is underway, but practitioners should note that key details—including the specific patent claims at issue, the identity of the petitioner and patent owner as reflected in the styled papers, and the precise invalidity combinations asserted—may develop as the record fills out.

A new post-grant review, PGR2026-00062, was filed at the Patent Trial and Appeal Board on June 25, 2026, in a matter captioned America Ugreen Limited. While the publicly available docket caption immediately identifies Ugreen as a party, patent professionals will want to watch for the petition, mandatory notices, and patent owner filings to clarify the full party alignment, the challenged claims, and the commercial context behind the dispute.

At this stage, the key takeaway is procedural as much as substantive: a post-grant review is only available for patents subject to the AIA’s first-inventor-to-file regime and allows challengers to press a broader range of invalidity theories than inter partes review.